PL2170297T3 - Preparat duloksetynowy - Google Patents

Preparat duloksetynowy

Info

Publication number
PL2170297T3
PL2170297T3 PL08762415T PL08762415T PL2170297T3 PL 2170297 T3 PL2170297 T3 PL 2170297T3 PL 08762415 T PL08762415 T PL 08762415T PL 08762415 T PL08762415 T PL 08762415T PL 2170297 T3 PL2170297 T3 PL 2170297T3
Authority
PL
Poland
Prior art keywords
duloxetine formulation
duloxetine
formulation
Prior art date
Application number
PL08762415T
Other languages
English (en)
Inventor
Rahul Sareen
Peter Henry Robert Persicaner
Original Assignee
Arrow International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arrow International Ltd filed Critical Arrow International Ltd
Publication of PL2170297T3 publication Critical patent/PL2170297T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08762415T 2007-06-23 2008-06-20 Preparat duloksetynowy PL2170297T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0712220.3A GB0712220D0 (en) 2007-06-23 2007-06-23 Duloxetine formulation
GBGB0804270.7A GB0804270D0 (en) 2007-06-23 2008-03-07 Duloxetine formulation
PCT/GB2008/002098 WO2009001043A2 (en) 2007-06-23 2008-06-20 Duloxetine formulation
EP08762415A EP2170297B1 (en) 2007-06-23 2008-06-20 Duloxetine formulation

Publications (1)

Publication Number Publication Date
PL2170297T3 true PL2170297T3 (pl) 2012-10-31

Family

ID=38352817

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08762415T PL2170297T3 (pl) 2007-06-23 2008-06-20 Preparat duloksetynowy

Country Status (11)

Country Link
US (1) US20080317845A1 (pl)
EP (1) EP2170297B1 (pl)
JP (1) JP2010530868A (pl)
CN (1) CN101686947A (pl)
AU (1) AU2008269626A1 (pl)
BR (1) BRPI0812107A2 (pl)
CA (1) CA2691371A1 (pl)
DK (1) DK2170297T3 (pl)
GB (2) GB0712220D0 (pl)
PL (1) PL2170297T3 (pl)
WO (1) WO2009001043A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2377525A1 (en) * 2010-03-26 2011-10-19 Laboratorios del Dr. Esteve S.A. Duloxetine enteric pellets
CN102579403B (zh) * 2011-12-26 2013-08-21 天津市嵩锐医药科技有限公司 盐酸度洛西汀药物组合物
CN103127023B (zh) * 2013-03-01 2014-08-27 河北天成药业股份有限公司 一种盐酸度洛西汀肠溶片及其制备方法
CN103393615B (zh) * 2013-07-24 2015-07-15 海南华益泰康药业有限公司 一种度洛西汀肠溶小丸及其制备方法
PL224543B1 (pl) 2013-08-21 2017-01-31 Pabianickie Zakłady Farm Polfa Spółka Akcyjna Dojelitowa tabletka duloksetyny
KR102242670B1 (ko) * 2014-01-09 2021-04-20 일동제약(주) 둘록세틴이 함유된 안정한 다중코팅 정제 조성물
JP6815109B2 (ja) * 2016-06-23 2021-01-20 キョーリンリメディオ株式会社 デュロキセチンまたは薬学的に許容されるその塩を有効成分とする医薬組成物
JP6866136B2 (ja) * 2016-11-30 2021-04-28 共和薬品工業株式会社 デュロキセチン塩酸塩を含む口腔内崩壊錠
JP6972674B2 (ja) * 2017-06-06 2021-11-24 ニプロ株式会社 経口医薬製剤
HRPK20190905B3 (hr) * 2019-05-16 2022-03-04 Anna POROPAT Sustav doziranja putem dozirnih opni za kontrolirano otpuštanje tvari iz spremnika

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US6193999B1 (en) * 1999-03-01 2001-02-27 Banner Pharmacaps, Inc. Gum acacia substituted soft gelatin capsules
JP2008543929A (ja) * 2005-06-20 2008-12-04 カディラ・ヘルスケア・リミテッド デュロキセチンの調節放出型の投与製剤
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
CA2651716A1 (en) * 2006-05-22 2007-12-06 Gershon Kolatkar Duloxetine hydrochloride delayed release formulations

Also Published As

Publication number Publication date
EP2170297B1 (en) 2012-08-08
GB0712220D0 (en) 2007-08-01
DK2170297T3 (da) 2012-10-15
WO2009001043A2 (en) 2008-12-31
CN101686947A (zh) 2010-03-31
GB0804270D0 (en) 2008-04-16
AU2008269626A1 (en) 2008-12-31
JP2010530868A (ja) 2010-09-16
BRPI0812107A2 (pt) 2014-11-25
WO2009001043A3 (en) 2009-03-12
US20080317845A1 (en) 2008-12-25
CA2691371A1 (en) 2008-12-31
AU2008269626A2 (en) 2010-01-07
EP2170297A2 (en) 2010-04-07

Similar Documents

Publication Publication Date Title
GB0608098D0 (en) Formulation
GB0700580D0 (en) Use
GB0821554D0 (en) Playard
GB0720716D0 (en) Novel formulation
ZA201004439B (en) Formulation
AP2010005314A0 (en) Nanodispersian
ZA200909137B (en) Applicator
PL2170297T3 (pl) Preparat duloksetynowy
GB0712503D0 (en) Use
GB0714670D0 (en) Use
GB0707463D0 (en) Formulation
GB0625312D0 (en) Formulation
GB0625095D0 (en) Formulation
GB0822633D0 (en) Formulation
EP2223811A4 (en) APPLICATOR
EP2285787A4 (en) 3-SUBSTITUTED PROPANAMINE COMPOUNDS
GB0800788D0 (en) Niovel formulation
IL183496A0 (en) Single use sinkstainer
GB0715723D0 (en) Formulation
GB0612809D0 (en) Formulation
GB0712972D0 (en) Formulation
GB0814376D0 (en) Formulation
ZA200806951B (en) Homeopathy-based formulation
GB0701096D0 (en) Use
GB0610570D0 (en) Novel formulation